<qa>  What is the duration of dual antiplatelet treatment?In some patients, the duration of dual antiplatelet treatment could be individualized taking into consideration the particular risks of that patients. In patients with very high bleeding risk e.g. patients with a history of repeated bleedings, the duration of dual antiplatelet treatment could be shortened to 6 weeks. After that, if a control TEE yields satisfactory results, clopidogrel could be discontinued and patients could be left on aspirin monotherapy only. Six-weeks of dual antiplatelet treatment has been recently shown to be sufficient after LAA occlusion. 16 On the other hand, in patients with a significant thrombotic risk e.g. with a history of repeated cardioembolic events, but without a history of overt bleeding, the duration of dual antiplatelet treatment could be prolonged to 6 months. The decision i.e., the assessment of the individual risk profile of an implanted patient and the patient-specific approach will be left to the discretion of the treating physician. 